Cargando…

Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis

Previous studies have shown that inhibition or depletion of N-acetyltransferase 1 (NAT1) in breast cancer cell lines leads to growth retardation both in vitro and in vivo, suggesting that NAT1 contributes to rapid growth of breast cancer cells. To understand molecular and cellular processes that NAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Kyung U., Gardner, Jonathan Q., Doll, Mark A., Stepp, Marcus W., Wilkey, Daniel W., Benz, Frederick W., Cai, Jian, Merchant, Michael L., Hein, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500399/ https://www.ncbi.nlm.nih.gov/pubmed/36158865 http://dx.doi.org/10.1016/j.toxrep.2022.07.010

Ejemplares similares

Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells
por: Hong, Kyung U., et al.
Publicado: (2022)

Folate-dependent hydrolysis of acetyl-coenzyme A by recombinant human and rodent arylamine N-acetyltransferases
por: Stepp, Marcus W., et al.
Publicado: (2015)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
por: Salazar-González, Raúl A., et al.
Publicado: (2022)

Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism
por: Stepp, Marcus W., et al.
Publicado: (2017)

Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2
por: Carlisle, Samantha M., et al.
Publicado: (2022)

Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes
por: Salazar-González, Raúl A., et al.
Publicado: (2020)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
por: Doll, Mark A., et al.
Publicado: (2017)

CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism
por: Carlisle, Samantha M., et al.
Publicado: (2020)

Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens
por: Hein, David W., et al.
Publicado: (2022)

Arylamine N-Acetyltransferases in Mycobacteria
por: Sim, Edith, et al.
Publicado: (2008)

N-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell Lines
por: Stepp, Marcus W., et al.
Publicado: (2019)

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
por: Fayez, Diman, et al.
Publicado: (2018)

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
por: Barra, Fabio, et al.
Publicado: (2018)

560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment
por: Doll, Mark A., et al.
Publicado: (2022)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
por: Laurieri, Nicola, et al.
Publicado: (2014)

Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa
por: Westwood, Isaac M, et al.
Publicado: (2007)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
por: Liu, Xinning, et al.
Publicado: (2021)

Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system
por: Wakefield, Larissa, et al.
Publicado: (2008)

Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
por: Sim, E, et al.
Publicado: (2014)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
por: Mahasneh, Amjad, et al.
Publicado: (2012)

Subcellular Protein Labeling by a Spatially Restricted Arylamine N-Acetyltransferase
por: Kleinpenning, Fleur, et al.
Publicado: (2018)

N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes.
por: Watanabe, M, et al.
Publicado: (1994)

Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2
por: Hong, Kyung U., et al.
Publicado: (2020)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
por: Vangenot, Christelle, et al.
Publicado: (2019)

Correction to Subcellular Protein Labeling by a Spatially Restricted Arylamine N-Acetyltransferase
por: Kleinpenning, Fleur, et al.
Publicado: (2019)

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N‐Acetyltransferase NAT2
por: Conway, Louis P., et al.
Publicado: (2020)

Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders
por: Hong, Kyung U., et al.
Publicado: (2023)

Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice
por: Camporez, João Paulo, et al.
Publicado: (2017)

Arylamines suppress their own activation and that of nitroarenes in V79 Chinese hamster cells by competing for acetyltransferases.
por: Kiefer, F, et al.
Publicado: (1994)

Polymorphisms in the Human Cytochrome P450 and Arylamine N-Acetyltransferase: Susceptibility to Head and Neck Cancers
por: Khlifi, Rim, et al.
Publicado: (2013)

Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver
por: Francis, Sheena, et al.
Publicado: (2016)

A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity
por: Turiján-Espinoza, Eneida, et al.
Publicado: (2018)

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines
por: Tiang, Jacky M, et al.
Publicado: (2015)

Identification of new arylamine N-acetyltransferases and enhancing 2-acetamidophenol production in Pseudomonas chlororaphis HT66
por: Guo, Shuqi, et al.
Publicado: (2020)

Arylamine N-Acetyltransferase 2 (NAT2) Genetic Diversity and Traditional Subsistence: A Worldwide Population Survey
por: Sabbagh, Audrey, et al.
Publicado: (2011)

Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine
por: Hou, Zhi-duo, et al.
Publicado: (2014)

Stable Isotope Tracing Reveals an Altered Fate of Glucose in N-Acetyltransferase 1 Knockout Breast Cancer Cells
por: Wise, James T. F., et al.
Publicado: (2023)

Piperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside Macrophages
por: Abuhammad, Areej, et al.
Publicado: (2012)

Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens
por: Duval, Romain, et al.
Publicado: (2016)

Cadmium Alters the Biotransformation of Carcinogenic Aromatic Amines by Arylamine N-Acetyltransferase Xenobiotic-Metabolizing Enzymes: Molecular, Cellular, and in Vivo Studies
por: Ragunathan, Nilusha, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ubiqme9s2tmj87pcu789dgilen